USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: BIOTEX, INC.
Address: 8058 EL RIO ST
HOUSTON, TX
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $5,274,235.00 39
SBIR Phase II $11,544,069.00 14
STTR Phase I $270,000.00 2

Award List:

NOVEL SKIN PORT DEVICE FOR BLOOD GLUCOSE SENSING

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gowda, ashok
Award Amount: $100,000.00

INTERACTIVE IMAGE GUIDED CLOSED LOOP THERMAL THERAPY

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mcnichols, Roger J
Award Amount: $100,000.00

INTEGRATED APPROACH FOR ENDOSCOPIC DETECTION OF CANCER

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $106,739.00
Abstract:
Not Available There is a need in both commercial and military applications for digital transmission methods that can operate at high data rates (several megabits per second end-user rate) in multi-user environments. Existing communication methods will be severely stressed by the requirements of… More

LASER CATHETER FOR ABLATION OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $112,231.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $374,858.00

Interactive Image Guided Closed Loop Thermal Therapy

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $374,858.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II Competing Continuation research project is to complete the Phase I clinical trial of a new magnetic resonance imaging guided minimally invasive treatment for focal brain tumors. Over the past four years, BioTex has developed the… More

N/A

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $99,563.00

Laser Cather for Ablation of Ventricular Tachycardia

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $0.00

Laser Cather for Ablation of Ventricular Tachycardia

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $371,076.00

LASER CATHETER FOR TREATMENT OF GASTROESOPHAGEAL REFLUX

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $100,000.00
Abstract:
DESCRIPTION ( Investigator's Abstract): The goal of this research is the development of a highly maneuverable, self-propelled gastrointestinal intervention system. The technology developed under this program is intended to greatly expand the range of diagnostic and therapeutic procedures… More

LASER TATTOO REMOVAL SYSTEM USING DERMAL CLEARING AGENT

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $100,000.00
Abstract:
DESCRIPTION: (Verbatim) - In recent years, the popularity of tattooing has grown tremendously with over 10 million Americans now believed to have one or more tattoos. Along with this demand for tattoos comes an increased demand for tattoo removal. A limitation of laser tattoo… More

NOVEL OPTICAL PROBE FOR ORAL AND DENTAL TISSUE SCREENING

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $100,000.00
Abstract:
DESCRIPTION: Currently under development is a novel optical probe for non-invasive characterization and monitoring of the biochemical and morphological changes in oral cavity epithelium leading to dysplasia and ultimately to invasive squamous cell… More

LASER DELIVERY SYSTEM FOR IMPROVED THERMAL THERAPY

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): The liver and brain are the most common sites of metastatic tumors. At the time of death, approximately two-thirds of patients with colorectal cancer have liver metastases. In addition approximately 83 percent of all brain cancers will be diagnosed as… More

Novel Optical System for Early Cervical Cancer Detection

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 13,000 cases of invasive cervical cancer will be diagnosed in the United States, in 2002, and approximately 4,100 women will die from the disease. The 5-year relative survival rate for the earliest stage of invasive cervical cancer is 91%. The… More

Percutaneous Vertebroplasty w/MR-Guided Laser Ablation

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $99,979.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 30-70% of all cancer patients will eventually experience tumor metastasis to the spine. Such tumors are often excruciatingly painful and debilitating to the patient. Treatment strategies for metastatic spinal lesions are palliative in nature and are… More

Laser Tattoo Removal System Using Dermal Clearing Agent

Award Year / Program / Phase: 2004 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $737,382.00
Abstract:
DESCRIPTION (provided by applicant): The focus of this research is to continue development of a device and technique for dermal clearing which will improve the efficacy of laser tattoo removal and other dermatological laser procedures including treatment of port wine stain and telangiectasia and… More

Percutaneous Vertebroplasty w/MR-Guided Laser Ablation

Award Year / Program / Phase: 2004 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $753,174.00
Abstract:
DESCRIPTION (provided by applicant): At least 65,000 cancer patients will develop symptomatic spinal metastatic lesions this year. Additionally, approximately 30-70% of all cancer patients exhibit spinal metastasis at autopsy indicating that the prevalence of problematic spinal tumors will increase… More

Image Guided Thermal Therapy for Prostate Cancer

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 190,000 new cases of prostate cancer will be diagnosed in the U.S. in 2003, and this year 30,400 American men will die from prostate cancer. In the United States, the annual cost of treating prostate cancer has reached $1.72 billion. While there are… More

Image Guided Thermal Therapy for Prostate Cancer

Award Year / Program / Phase: 2004 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $749,652.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 190,000 new cases of prostate cancer will be diagnosed in the U.S. in 2003, and this year 30,400 American men will die from prostate cancer. In the United States, the annual cost of treating prostate cancer has reached $1.72 billion. While there are… More

A Wearable Fluorescence Spectrometer for Transdermal Glucose Monitoring

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency / Branch: DOD / OSD
Principal Investigator: Ralph Ballerstadt, Senior Research Scientist
Award Amount: $100,000.00
Abstract:
The focus of this research project is to design and evaluate a first-generation prototype of a wearable fluorescence detector and display device for transdermal glucose monitoring. The unique feature of the detector and readout device is its high specificity and selectivity for the glucose… More

Fluorescence Sensor Probe for Glucose Sensing

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Diabetes mellitus is a metabolic disease, which currently afflicts some 16 million in the US and 100 million people worldwide. In the US, diabetes and its associated complications are the seventh leading cause of death. Effective management of diabetes… More

Cooled Laser Delivery System: Improved Thermal Therapy

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $739,092.00
Abstract:
DESCRIPTION (provided by applicant): The focus of this research is to continue development of a novel interstitial cooled laser delivery system for improved thermal therapy. The system is intended to find applications in the thermal destruction of cancerous tumors. Laser interstitial thermal… More

Nanoparticle-Based Optical Sensor for Glucose Monitoring

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $396,937.00
Abstract:
DESCRIPTION (provided by applicant): Diabetes mellitus is a metabolic disease which currently afflicts some 16 million in the US and 100 million people worldwide. In the US, diabetes and its associated complications are the seventh leading cause of death. Effective management of diabetes requires… More

Interactive Image Guided Closed Loop Thermal Therapy

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $2,016,807.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II Competing Continuation research project is to complete the Phase I clinical trial of a new magnetic resonance imaging guided minimally invasive treatment for focal brain tumors. Over the past four years, BioTex has developed the… More

Novel Optical Probe for Oral and Dental Tissue Screening

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $756,569.00
Abstract:
DESCRIPTION (provided by applicant): We will continue development of a novel optical probe for non-invasive characterization and monitoring of the biochemical and morphological changes in oral cavity epithelium leading to dysplasia and ultimately to invasive squamous cell carcinoma. Oral squamous… More

Monitoring Microbes in the Spacecraft Environment by Mass Spectrometry of Ribosomal RNA

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: NASA
Principal Investigator: George W. Jackson, Principal Investigator
Award Amount: $70,000.00
Abstract:
The unique stresses in the spacecraft environment including isolation, containment, weightlessness, increased radiation exposure, and enhanced microbial contamination have resulted in a compromise of the immune system in every human or animal that has ever flown in space. Identifying and monitoring… More

High-Throughput Microbial Monitoring of Food and Water by Mass Spectrometry of Ribosomal RNA

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: USDA
Principal Investigator: George W. Jackson, Research Scientist
Award Amount: $70,965.00
Abstract:
Rapid, exploratory diagnostics are needed for the identification of bacteria in complex food and water samples. This project focuses on development of a novel, rapid system for molecular identification of bacteria.

5-Day Fiber-Coupled Sensor Interstitial Glucose

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I project is to develop a first-generation prototype interstitial glucose sensor designed for 3 to 5 day monitoring in diabetic patients. We have previously demonstrated the success of a fluorescence (FRET-based) approach with an improved… More

Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson
Award Amount: $106,944.00
Abstract:
DESCRIPTION (provided by applicant): The World Health Organization estimates that over 1,600 people die each hour from an infectious disease, half of whom are children under 5 years of age. Infectious diseases account for 26 percent of total global mortali ty and are the third leading cause of death… More

Fluorescence Sensor Probe for Transcutaneous Glucose Sensing

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $746,655.00
Abstract:
DESCRIPTION (provided by applicant): There is an urgent need for a long-term in vivo glucose-monitoring device for diabetes therapy. Diabetes is currently believed to afflict over 100 million people worldwide and nearly 18 million in the United States. In the U.S. this disorder, along with its… More

Sensitive, Quantitative, and Portable Anatoxin Assay using Aptamers and Quantum Dot Nanoshell Reporting

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: EPA
Principal Investigator: George W. Jackson, Research Scientist
Award Amount: $69,961.00
Abstract:
This proposed project directly addresses an U.S. Environmental Protection Agency (EPA) calling for improved detection and measurement techniques including screening kits for algal neurotoxins (especially cyanobacterial anatoxin) and cytotoxins in drinking water systems. Bloom-forming cyanobacteria… More

STTR Phase I: Scaleable, Inexpensive Production of siRNA in E. coli

Award Year / Program / Phase: 2008 / STTR / Phase I
Agency: NSF
Research Institution: University of Houston
Principal Investigator: George W. Jackson, DPhil
Award Amount: $150,000.00
RI Contact: George Fox
Abstract:
This Small Business Technology Transfer Phase I project develops molecular biology, biochemical engineering, and purification techniques to provide small interfering RNA or siRNA molecules on at large-scale and at low cost compared to available techniques. In recent years, siRNA's have been… More

Interstitial Laser Ablation System for Thyroid Nodules

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $119,448.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I proposal is to explore the technical feasibility of minimally invasive ultrasound-guided laser ablation of symptomatic thyroid nodules. Under previous SBIR support, we have developed a cooled la ser delivery system for improved laser… More

Temperature Gradient Hybridizer and Real-time Imager for DNA Microarrays

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson
Award Amount: $111,945.00
Abstract:
DESCRIPTION (provided by applicant): Because of the large amount of genetic information which can be rapidly accessed, DNA microarrays have become indispensable tools for biological investigations. Despite their utility, however, a number of experimental d ifficulties have resulted in widely varying… More

In vivo Selection of Ribosomal Aptamers for Improved Bioremediation

Award Year / Program / Phase: 2008 / STTR / Phase I
Agency: HHS
Research Institution: N/A
Principal Investigator: George W. Jackson
Award Amount: $120,000.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Bioremediation technologies use microorganisms to reduce, eliminate, contain, or transform to benign products contaminants present in soils, sediments, water, and air. While biological treatment of domestic and industri al waste has been employed for some time,… More

Platform for Massively Parallel Selection of Aptamer Ligands

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson
Award Amount: $123,624.00
Abstract:
DESCRIPTION (provided by applicant): Aptamers have emerged as one of the most promising classes of drug leads and diagnostic ligands presently available. Aptamers, nucleic acid ligands derived from large combinatorial libraries, typically have affinities a nd specificities that rival antibodies, yet… More

Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: George W. Jackson
Award Amount: $722,491.00
Abstract:
DESCRIPTION (provided by applicant): The World Health Organization estimates that over 1,600 people die each hour from an infectious disease, half of whom are children under 5 years of age. Infectious diseases account for 26 percent of total global mortali ty and are the third leading cause of death… More

5-Day Fiber-Coupled Fluorescense Sensor for Interstitial Glucose Monitoring

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $788,637.00
Abstract:
DESCRIPTION (provided by applicant): There is an urgent need for a long-term in vivo glucose-monitoring device for diabetes therapy. Diabetes is currently believed to afflict over 100 million people worldwide and nearly 18 million in the United States. In the U.S. this disorder, along with its… More

Assay for Monitoring Glycemic Control in Diabetics

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $499,652.00
Abstract:
DESCRIPTION (provided by applicant): Diabetes is currently believed to afflict over 100 million people worldwide and nearly 18 million in the United States. In the U.S. this disorder, along with its associated complications, is ranked as the seventh leadin g cause of death. To significantly improve… More

Aptamer Coatings for Improved Host Response of Biomedical Implants

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt
Award Amount: $122,181.00
Abstract:
DESCRIPTION (provided by applicant): Current focus in improving acceptance of implants is to engineer materials that proactively control the interaction of the material surface with the biological milieu. Such control could ultimately lead to implants with long-term operational functionality due to… More

3D Tracking for OCT Image Fusion in Gynecological Diagnosis

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols
Award Amount: $115,765.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I SBIR proposal is to develop a navigation and image fusion system for improved diagnosis of cervical cancers and pre-cancers. The system will combine optical coherence tomography (OCT) imaging wi th traditional colposcopy (with or without… More

Endoscopic Tool for Small Animal Intubation

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Seifu Teferra
Award Amount: $107,856.00
Abstract:
DESCRIPTION (provided by applicant): The importance of in vivo small animal research to the scientific community cannot be overestimated. Along with the advantages of small animal manipulations come inherent difficulties, among them intubations which are o ften necessary for inhalation anesthesia.… More

Local Hyperthermia Catheter for Enhanced Ablation and Cancer Therapy

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ashok Gowda
Award Amount: $151,128.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I SBIR Grant Proposal is to develop a new device and methodology for local elevation of a target tissue's temperature prior to a planned thermal ablation, a process we've dubbed hyperablation . I n preliminary work we demonstrated that… More

DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson – (713) 741-0111
Award Amount: $149,800.00
Abstract:
Thousands of antibodies are produced every year by commercial companies. However, many of these antibodies are known to be poorly characterized and suboptimal across multiple applications. Polyclonal  antibodies lack the reproducibility of monoclonal antibodies. Likewise, the production of… More

Laser Catheter for Bronchial Treatment of Severe Asthma

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols – 713-741-0111
Award Amount: $150,000.00
Abstract:
DESCRIPTION (provided by applicant): Asthma afflicts as many as 39 million Americans and some 4,000 will die of the disease each this year. The goal of this Phase I SBIR proposal is to design, develop, build, and test a novel, cooled laser catheter for effecting Bronchial Thermoplasty in a safe and… More

Platform for Massively Parallel Selection of Aptamer Ligands

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: George W. Jackson – 713-741-0111
Award Amount: $976,993.00
Abstract:
DESCRIPTION (provided by applicant): Aptamers have emerged as one of the most promising classes of drug leads and diagnostic ligands presently available. Aptamers, nucleic acid ligands derived from large combinatorial libraries, typically have affinitiesand specificities that rival antibodies, yet… More

SBIR TOPIC 294 PHASE 1 - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson – 713-741-0111
Award Amount: $149,919.00
Abstract:
The carbohydrate modification O-GlcNAc is nearly as abundant as protein phosphorylation in proteins, competes with it, and has extensive crosstalk to regulate signaling, transcription, and the functions of oncogenes and tumor suppressors. However, analysisof protein O-GlcNAcylation currently… More

3D Tracking for OCT Image Fusion in Gynecological Diagnosis

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Roger J. Mcnichols – 713-741-0111
Award Amount: $1,060,687.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to continue development of an exciting platform based on integration of optical coherence tomography acquisition with real-time 3D spatial localization. In Phase I, in the context of gynecological diagnostic imaging, we… More

Aptamer-based Insulin Detection Device

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt – 713-741-0111
Award Amount: $162,817.00
Abstract:
DESCRIPTION (provided by applicant): The objective of the phase I proposal is to demonstrate the feasibility of a new and innovative insulin assay for its integration in a small benchtop device with the focus in clinical diabetes therapy: A) for assessmentof insulin impairment in type II diabetics,… More

Affinity Sensor-based Dual-Hormone Closed-Loop Glucose Control System

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ralph Ballerstadt – 713-741-0111
Award Amount: $292,110.00
Abstract:
DESCRIPTION (provided by applicant): The World Health Organization estimates that diabetes affects about 185 million people worldwide, with approx. 20 million individuals (approx. 6 percent by population) afflicted in the US (approx. 10 percent of this type 1 diabetes). Tighter glucose control… More

Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Jackson – 713-741-0111
Award Amount: $248,891.00
Abstract:
DESCRIPTION (provided by applicant): Project Summary The goal of this NIH-SBIR Phase I proposal is to develop a new point-of-care (POC) detection platform and methodology for assessment of human exposure to hazardous environmental compounds in the bloodstream. Because the mechanisms of transport of… More

Minimally Invasive Image-Guided Laser Treatment of Epilepsy

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Roger J. Mcnichols – 713-741-0111
Award Amount: $160,922.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I SBIR application is to develop a new minimally invasive therapy for laser ablation of epileptogenic seizure foci. There is a large unmet need for better treatment options for the nearly one million epilepsy patients in the U.S. that are… More

IGF::OT::IGF OTHER FUNCTIONS SBIR PHASE II, TOPIC 22, DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS FOR CANCER PROTEOMICS RESEARCH

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: George Jackson – 713-741-0111
Award Amount: $749,996.00
Abstract:
Thousands of antibodies are produced every year by commercial companies. However, many of these antibodies are known to be poorly characterized and suboptimal across applications. Polyclonal antibodies lack the reproducibility of monoclonal antibodies. Theproduction of monoclonal antibodies is… More